Abiopharma

🔍 Ortiz Blanes Jacobo (Executive)

Company: Fermi Inc. (FRMI)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 147,059 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,616,151.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 7,875,000.00 | Footnotes: F1

Footnotes:

• F1: Reflects shares of common stock of the Issuer directly held by Las Brisas Financial Services LLC ("Las Brisas"). Mr. Ortiz is a managing member of Las Brisas and may be deemed to beneficially own common stock of the Issuer held by Las Brisas. Mr. Ortiz disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that Mr. Ortiz is the beneficial owner of such securities for purposes of Sections 13 or 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
• F2: Represents an award of restricted stock units ("RSUs") of the Issuer granted to Mr. Ortiz under the Issuer's 2025 Long-Term Incentive Plan that will generally vest in one-third installments on the first, second, and third anniversaries of the date of grant, in each case subject to Mr. Ortiz' continued service relationship with the Issuer through such date.
• F3: Includes 4,347,059 shares of restricted common stock of the Issuer subject to time-based vesting conditions.